Lack of information regarding the natural history and prognosis of the syndrome has made evaluation of therapy virtually impossible.
Keen interest greeted the suggestion of Frohlich et al 1 that at least some of these patients suffer from hyperresponsiveness of their cardiac beta-adrenergic receptors.